Celldex Therapeutics, Inc. Deferred Revenue Recognized
Celldex Therapeutics, Inc. (CLDX) reported Deferred Revenue Recognized of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Other Income
us-gaap:ContractWithCustomerLiabilityRevenueRecognized · last filed 2026-08-06
- Celldex Therapeutics, Inc. contract with customer, liability, revenue recognized for the quarter ending 2026-03-31 was $0.00.
- Celldex Therapeutics, Inc. contract with customer, liability, revenue recognized for the quarter ending 2024-03-31 was $200.00K.
- Celldex Therapeutics, Inc. contract with customer, liability, revenue recognized for the quarter ending 2023-03-31 was $0.00, a 100.00% decline year-over-year.
- Celldex Therapeutics, Inc. contract with customer, liability, revenue recognized for the quarter ending 2022-09-30 was $200.00K.
- Celldex Therapeutics, Inc. contract with customer, liability, revenue recognized for fiscal 2024 was $3.10M, a 3000.00% increase from fiscal 2023.
- Celldex Therapeutics, Inc. contract with customer, liability, revenue recognized for fiscal 2023 was $100.00K, a 75.00% decline from fiscal 2022.
- Celldex Therapeutics, Inc. contract with customer, liability, revenue recognized for fiscal 2022 was $400.00K, a 88.24% decline from fiscal 2021.
- Celldex Therapeutics, Inc. contract with customer, liability, revenue recognized for fiscal 2021 was $3.40M, a 1600.00% increase from fiscal 2020.
| Period end | Contract with Customer, Liability, Revenue Recognized 3 month | Contract with Customer, Liability, Revenue Recognized 6 month | Contract with Customer, Liability, Revenue Recognized 9 month | Contract with Customer, Liability, Revenue Recognized 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-06 | |||
| 2026-03-31 | $0.00 10-Q · filed 2026-05-07 | |||
| 2024-12-31 | $3.10M 10-K · filed 2025-02-27 | |||
| 2024-09-30 | $2.80M 10-Q · filed 2024-11-06 | |||
| 2024-06-30 | $300.00K 10-Q · filed 2024-08-08 | |||
| 2024-03-31 | $200.00K 10-Q · filed 2024-05-06 | |||
| 2023-12-31 | $100.00K 10-K · filed 2024-02-26 | |||
| 2023-06-30 | $100.00K 10-Q · filed 2023-08-08 | |||
| 2023-03-31 | $0.00 10-Q · filed 2023-05-04 | |||
| 2022-12-31 | $400.00K 10-K · filed 2023-02-28 | |||
| 2022-09-30 | $200.00K 10-Q · filed 2022-11-09 | $400.00K 10-Q · filed 2022-11-09 | ||
| 2022-06-30 | $100.00K 10-Q · filed 2022-08-08 | $200.00K 10-Q · filed 2022-08-08 | ||
| 2022-03-31 | $100.00K 10-Q · filed 2022-05-05 | |||
| 2021-12-31 | $3.40M 10-K · filed 2022-02-28 | |||
| 2021-09-30 | $0.00 10-Q · filed 2021-11-09 | $3.40M 10-Q · filed 2021-11-09 | ||
| 2021-06-30 | $3.00M 10-Q · filed 2021-08-05 | $3.40M 10-Q · filed 2021-08-05 | ||
| 2021-03-31 | $400.00K 10-Q · filed 2021-05-06 | |||
| 2020-12-31 | $200.00K 10-K · filed 2021-03-29 | |||
| 2020-09-30 | $0.00 10-Q · filed 2020-11-05 | $200.00K 10-Q · filed 2020-11-05 | ||
| 2020-06-30 | $0.00 10-Q · filed 2020-08-06 | $100.00K 10-Q · filed 2020-08-06 | ||
| 2020-03-31 | $100.00K 10-Q · filed 2020-05-06 | |||
| 2019-12-31 | $1.40M 10-K · filed 2020-03-26 | |||
| 2019-09-30 | $100.00K 10-Q · filed 2019-11-12 | $1.30M 10-Q · filed 2019-11-12 | ||
| 2019-06-30 | $400.00K 10-Q · filed 2019-08-07 | $1.20M 10-Q · filed 2019-08-07 | ||
| 2019-03-31 | $800.00K 10-Q · filed 2019-05-07 | |||
| 2018-12-31 | $1.90M 10-K · filed 2019-03-07 | |||
| 2018-09-30 | $0.00 10-Q · filed 2018-11-07 | $1.50M 10-Q · filed 2018-11-07 | ||
| 2018-06-30 | $1.00M 10-Q · filed 2018-08-08 | $1.50M 10-Q · filed 2018-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |